PE
ANGO icon

Point72 Europe’s AngioDynamics ANGO Stock Holding History

Point72 Europe’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$556 Buy
+50
New +$483 ﹤0.01% 708

Other funds holding ANGO

DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
BAM
Bastion Asset Management Montreal, Canada $328M AUM 13.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Point72 Europe's ANGO Position: Q3 2025 in Review

Point72 Europe opened a new position in AngioDynamics (ANGO) in Q3 2025: 50 shares worth $556. The stake represents ﹤0.01% of the portfolio and ranks #708 among its holdings.

144 funds tracked by Wall St. Rank hold ANGO as of Q3 2025.

  • Point72 Europe held 50 shares of AngioDynamics worth $556 as of Q3 2025.
  • AngioDynamics was a new Point72 Europe position in Q3 2025.
  • AngioDynamics made up ﹤0.01% of Point72 Europe's portfolio in Q3 2025, its #708 holding.
  • 144 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2025.

Based on Point72 Europe's 13F filing for Q3 2025, filed 14 Nov 2025.